Abstract
Objective
To describe the epidemiological characteristics of pertussis cases reported to Mazandaran Center for Diseases Control and Prevention (P-CDC) during the years 2008–2011 in Mazandaran, North of Iran.
Methods
The patients included were those who fulfilled the WHO definition for pertussis or those clinically diagnosed by physicians. The demographic features of cases, their vaccination status, the incidence rate per 100,000 population, the relative proportion of cases for each age group, and their relation to vaccination status of the patients were all determined.
Results
During the study period, a total of 518 cases of pertussis were reported; of which 43 were confirmed. The highest incidence rate and the largest proportion were 135.5 cases/100,000 and 37.7 %, respectively, observed in infants <12 mo of age. Almost 35.7 % of the cases were under vaccinated, however 54.4 % of them were fully vaccinated.
Conclusions
Pertussis infection has re-emerged in Mazandaran. It has caused a significant health problem in the susceptible young infants, and also among completely vaccinated children. Implementing strategies to protect these vulnerable infants and studies to evaluate the immunogenicity and efficacy of pertussis vaccine in Iran is recommended. It was difficult to confirm pertussis in the majority of cases, therefore, providing and improving laboratory diagnostic methods seems to be an urgent requirement.
Similar content being viewed by others
References
Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin, Cherry, Demmeler, Harison, Kaplan, editors. Textbook of pediatric infectious diseases. 6th ed. USA: Elsevier Saunders; 2009. p. 1683–706.
Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin, Orenstein, Offit, editors. Vaccines. 5th ed. USA: Elsevier Saunders; 2008. p. 467–517.
Cherry JD, Tan T, von König CH W, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54:1756–64.
Global Immunization Data. World Health Organization—UNICEF. Global immunization coverage in 2009: December 2010.
Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin Infect Dis. 2000;6:348–57.
Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121:484–92.
Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3:183–8.
Celentano LP, Massari M, Paramatti D, Salmaso S. Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761–5.
Global Advisory Group. Expanded programme on immunization. Wkly Epidemiol Rec. 1981;56:9–16.
Esteghamati MR, Mansour ghanei R. Guidelines for surveillance of pertussis (pamphelel). Tehran:centers for diseases control and prevention. Deputy of Health: Ministry of health and Medication Education 2009.
Goya MM. Pertussis reemergence notification. Tehran, Center of Diseases Control and Prevention. Deputy of Health and Medical Education: No 24740:20, February 2007.
Saffar MJ, Khalilian AR, Rafee AR, Parsaei MR, Imanikhani S, Shojaei J, et al. Bordetella pertussis IgG and IgA antibodies seroprevalence among 1–35 y-old population: The role of subclinical pertussis infection. Indian J Pediatr. 2012;79:353–7.
Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25–34.
Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58–61.
Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006;25:361–2.
Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J. 2005;24:S62–5.
Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006;42:1439–42.
Gonik B, Puder KS, Gonik N, Kruger M. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol. 2005;13:59–61.
Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr. 2007;44:916–8.
Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther. 2010;32:1479–95.
McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis. 2009;22:215–23.
Forsyth KD, von Konig CH W, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second global pertussis initiative roundtable meeting. Vaccine. 2007;30(25):2634–42.
Munozf, England J. Infact pertussis: is cocooning the answer. Clin Infect Dis. 2011;53:885–92.
Mohammed-Jafar S, Abolghasem A, Narges M, Hiva S, Ali-Reza K. Prepregnancy pertussis immunization: effect on materno-neonatal antibody titers and infant immune response to whole-cell pertussis vaccination. J Vaccine. 2012;3:7. doi:10.4172/2157-7560.1000157.
Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614–24.
Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011;24:190–5.
Strebel PM, Cochi SL, Farizo KM, Payne BJ, Hanauer SD, Baughman AL. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis. 1993;16:276–85.
Schmidt-Schläpfer G, Liese JG, Porter F, Stojanov S, Just M, Belohradsky BH. Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children. Clin Microbiol Infect. 1997;3:462–7.
Heininger U, Schmidt-Schläpfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics. 2000;105:E31.
Contributions
MJS: Chief executive designer of the study and wrote the manuscript; GG and AH: Implementation of the study and collection of medical records; MSR: Designing of the study, analyzing the data, drafting the manuscript and will act as guarantor for this paper.
Conflict of Interest
None.
Role of Funding Source
This project was funded by the Vice Chancellor for Research, Mazandaran University Medical Sciences, Iran.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saffar, M.J., Ghorbani, G., Hashemi, A. et al. Pertussis Resurgence in a Highly Vaccinated Population, Mazandaran, North of Iran 2008–2011: An Epidemiological Analysis. Indian J Pediatr 81, 1332–1336 (2014). https://doi.org/10.1007/s12098-014-1445-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1445-0